Consolidated Edison, Inc. (ED) Stock Forecast
Data as of May 2, 2026Utilities · Current price $110.94 (-0.50%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 23, 2026 | Anthony Crowdell | Mizuho Securities | $118.00 | +6.4% |
| Jan 23, 2026 | Stephen D'Ambrisi | RBC Capital | $118.00 | +6.4% |
| Jan 23, 2026 | William Appicelli | UBS | $112.00 | +1.0% |
| Nov 20, 2025 | David Arcaro | Morgan Stanley | $98.00 | -11.7% |
| Oct 27, 2025 | Shahriar Pourreza | Wells Fargo | $99.00 | -10.8% |
| Oct 22, 2025 | David Arcaro | Morgan Stanley | $100.00 | -9.9% |
| Oct 15, 2025 | Sophie Karp | KeyBanc | $90.00 | -18.9% |
| Aug 13, 2025 | Nicholas Campanella | Barclays | $107.00 | -3.5% |
| Aug 11, 2025 | Andrew Weisel | Scotiabank | $106.00 | -4.4% |
| Jul 16, 2025 | Sophie Karp | KeyBanc | $88.00 | -20.7% |
| Apr 23, 2025 | David Arcaro | Morgan Stanley | $94.00 | -15.3% |
| Nov 8, 2024 | Shahriar Pourreza | Guggenheim | $99.00 | -10.8% |
| Oct 15, 2024 | Ryan Levine | Citigroup | $116.00 | +4.6% |
| Sep 25, 2024 | David Arcaro | Morgan Stanley | $87.00 | -21.6% |
| Aug 23, 2024 | David Arcaro | Morgan Stanley | $82.00 | -26.1% |
| Aug 5, 2024 | Julien Dumoulin-Smith | Bank of America Securities | $109.00 | -1.7% |
| Jul 22, 2024 | Nicholas Campanella | Barclays | $92.00 | -17.1% |
| Jul 19, 2024 | William Appicelli | UBS | $96.00 | -13.5% |
| May 28, 2024 | Anthony Crowdell | Mizuho Securities | $95.00 | -14.4% |
| May 6, 2024 | Nicholas Campanella | Barclays | $97.00 | -12.6% |
Top Analysts Covering ED
ED vs Sector & Market
| Metric | ED | Utilities Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.60 | 2.60 | 2.41 |
| Analyst Count | 15 | 9 | 18 |
| Target Upside | -1.9% | +49.9% | +14.9% |
| P/E Ratio | 19.63 | -3.40 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $17.05B | $17.41B | $17.80B | 10 |
| 2027-12-31 | $17.92B | $18.16B | $18.68B | 11 |
| 2028-03-31 | $4.12B | $4.21B | $4.34B | 2 |
| 2028-06-30 | $3.31B | $3.38B | $3.49B | 1 |
| 2028-09-30 | $4.18B | $4.27B | $4.41B | 1 |
| 2028-12-31 | $3.79B | $3.87B | $3.99B | 2 |
| 2029-03-31 | $4.68B | $4.77B | $4.93B | 3 |
| 2029-06-30 | $4.74B | $4.84B | $5.00B | 2 |
| 2029-09-30 | $4.81B | $4.91B | $5.07B | 2 |
| 2029-12-31 | $4.87B | $4.97B | $5.14B | 3 |
| 2030-12-31 | $19.12B | $19.89B | $20.60B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.00 | $6.10 | $6.19 | 10 |
| 2027-12-31 | $6.09 | $6.49 | $6.67 | 10 |
| 2028-03-31 | $2.28 | $2.34 | $2.44 | 3 |
| 2028-06-30 | $0.85 | $0.87 | $0.91 | 2 |
| 2028-09-30 | $2.28 | $2.34 | $2.44 | 2 |
| 2028-12-31 | $1.20 | $1.23 | $1.28 | 3 |
| 2029-03-31 | $2.33 | $2.39 | $2.49 | 2 |
| 2029-06-30 | $0.90 | $0.92 | $0.96 | 1 |
| 2029-09-30 | $2.41 | $2.47 | $2.58 | 1 |
| 2029-12-31 | $1.35 | $1.39 | $1.45 | 2 |
| 2030-12-31 | $7.33 | $7.72 | $8.07 | 2 |
Frequently Asked Questions
What is the analyst consensus for ED?
The consensus among 15 analysts covering Consolidated Edison, Inc. (ED) is Sell with an average price target of $106.80.
What is the highest price target for ED?
The highest price target for ED is $118.00, set by Anthony Crowdell at Mizuho Securities on 2026-02-23.
What is the lowest price target for ED?
The lowest price target for ED is $71.00, set by Eric Beaumont at Barclays on 2021-11-30.
How many analysts cover ED?
15 analysts have issued ratings for Consolidated Edison, Inc. in the past 12 months.
Is ED a buy or sell right now?
Based on 15 analyst ratings, ED has a consensus rating of Sell (3.60/5) with a -1.9% upside to the consensus target of $106.80.
What are the earnings estimates for ED?
Analysts estimate ED will report EPS of $6.10 for the period ending 2026-12-31, with revenue estimated at $17.41B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.